Detailed Narrative
Strong Q1 FY27 Performance Driven by Lab-Grown Diamond Exports
Goldiam International Limited reported a robust Q1 FY27, with total revenue reaching INR 363.7 crores. EBITDA surged by 120% to INR 103.9 crores, and profit after tax more than doubled to INR 74 crores. The company achieved a steady-state EBITDA margin of 24%, an increase of 400 basis points, attributed to the dual and hybrid casting method. Lab-grown diamond jewelry exports continued to be the primary growth driver, contributing 90.7% to the overall export sales mix, up from 87.8% in Q1 FY26.
Expanding Order Book and Market Share Potential
The company's order book position as of June 30, 2026, stood at INR 225 crores, marking a significant increase from INR 140 crores in the prior year's corresponding quarter. Management expressed confidence in a robust Q2 and Q3, building on this strong order book. Goldiam sees substantial scope to triple or quadruple its annual sales of USD 35-40 million with its largest US customer, which currently represents only 2% of that customer's wholesale purchase value.
ORIGEM Retail Brand Continues Investment Phase
The India-focused B2B lab-grown diamond jewelry retail brand, ORIGEM, recorded a revenue of INR 8.156 crores in Q1 FY27 but incurred an operating loss of INR 5-6 crores. The company plans to open 7 additional ORIGEM stores before Diwali, adding to its existing 26 operational stores. Management is focused on increasing sales per store through various enablers and aims for mature stores to achieve monthly run rates of INR 40-45 lakhs within the next one to two quarters.
Strategic Focus on Design, Manufacturing, and Supply Chain
Goldiam leverages its global design experience to introduce high-quality designs to ORIGEM, with many rings having sold over 200-250 times globally before their India launch. The company's expertise in manufacturing, diamond sourcing, and design, combined with a strong retail team, underpins its distribution strategy. Management views the increasing supply of lab-grown diamonds, including from Chinese CVD manufacturers, as beneficial, enhancing its supply chain strength as a pure-play jewelry manufacturer and distributor.
Lab-Grown Diamond Market Dynamics and Pricing Stability
Management noted that lab-grown diamond prices have reached a base, with some smaller sizes even seeing upward movement this quarter. They believe there is no large scope for price erosion from current levels. The US market for finished lab-grown diamond jewelry is experiencing healthy double-digit growth, and major US retailers are transitioning towards a predominant lab-grown diamond showcase, which Goldiam expects to continue for the medium to longer term.
Capital Allocation and Shareholder Returns
As of June 30, 2026, Goldiam held strong cash and cash equivalents, including investments, totaling INR 456.67 crores. In July, the company allotted 3,76,39,281 equity shares of INR 2 each as fully paid-up bonus equity shares in a 1:3 proportion, utilizing INR 7.52 crores from its reserves. This reflects the company's commitment to shareholder returns and efficient capital management.